Nikki Reeves

is a partner in King & Spalding’s FDA & Life Sciences Practice Group in Washington, D.C. She counsels pharmaceutical, biotechnology, and medical device companies on a broad range of FDA and healthcare regulatory compliance matters, including clinical trial regulation, product advertising/promotion, quality system regulation/good manufacturing practices, FDA enforcement actions, and federal healthcare compliance programs. Nikki is an expert on state aggregate spend disclosure laws targeting the pharmaceutical and device industries and the federal Physician Payment Sunshine provisions enacted as part of healthcare reform and implemented by CMS.

She leads the Ad Hoc Sunshine and State Law Compliance Group, a coalition of pharmaceutical and medical device manufacturers that she advises on these state and federal transparency/disclosure laws. She also leads the International Marketing and Disclosure Compliance Group, a separate coalition of pharmaceutical manufacturers, on the growing area of global transparency/disclosure laws and industry codes of conduct applicable to the pharma and medical device industry.

Nikki is a frequent speaker for the Pharmaceutical Compliance Forum and the Food and Drug Law Institute. She serves on the FDLI Food and Drug Law Journal Editorial Advisory Board. She has published several articles on FDA regulation of medical device and prescription drug advertising/promotion, the new federal Physician Payment Sunshine Reporting rule, and state laws regulating drug and device industry marketing practices.